Savvy

In this week’s issue of The Savvy Diabetic: Drug Cuts Albuminuria in Type 1 Diabetic Kidney Disease, Too Tandem Diabetes Care launches Mobi pump on Android phones Sandoz receives US …

In this week’s issue of The Savvy Diabetic: Drug that targets immune cells shows potential as new treatment for diabetic heart disease $3.1 Million NIH Grant to Develop Ketone-Aware Automated …

In this week’s issue of The Savvy Diabetic:  Diabeloop’s DBLG2 cleared for automated insulin delivery without meal input Medtronic wins expanded FDA label for 780G insulin pump Portal Diabetes Gets …

In this week’s issue of The Savvy Diabetic: Inside Eversense’s Next-Generation Implantable CGMs in Development An Implantable Artificial Pancreas Is Coming – How it Works Oral drug may allow early …

In this week’s issue of The Savvy Diabetic:  Medicare Telehealth Coverage Extended Through 2027 Recall: Abbott Diabetes FreeStyle Libre 3 & FreeStyle Libre 3+ sensors Advocacy: Thank Congress for Continuing …

In this week’s issue of The Savvy Diabetic:  CamDiab earns CE mark for fully closed-loop insulin delivery algorithm Senseonics Receives European Approval for Eversense 365 Dexcom G8: Dexcom CEO Hints …

In this week’s issue of The Savvy Diabetic:  What’s Next for Omnipod BetaBionics’ iLet and MAUDE Red Flag on Severe Hypos Breakthrough T1D Awards $1.5 Million Grant to Blue Circle …

In this week’s issue of The Savvy Diabetic:  Sequel Med Tech, Diabeloop to Integrate Automated Insulin Delivery Algorithm into twiist Pump A “twiist” of Fate: Why Sequel is Moving Beyond …

In this week’s issue of The Savvy Diabetic:  Senseonics Launches Eversense 365 CGM with Sequel twiist Pump Global Economic Burden of Diabetes to Exceed $10 Trillion Implantable Device Containing Islet …

In this week’s issue of The Savvy Diabetic: Why MARD Is the Wrong Headline Metric for CGM Performance Semaglutide Benefits Extend to Type 1 Diabetes Five Biotech Companies Moving Past …